MedPath
NMPA Approval

Cefprozil for Suspension

国药准字H20103106

September 27, 2019

Drug Information

头孢丙烯干混悬剂

金石

干混悬剂

按C18H19N3O5S计0.25g

化学药品

September 27, 2019

Company Information

Applicant Company

汕头市泰山路36号

Manufacturing Company

汕头市泰山路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢丙烯干混悬剂 - NMPA 批准文号 | MedPath